Gepirone
New Drug Approvals
JUNE 11, 2025
2] Gepirone was synthesized by Bristol-Myers Squibb in 1986 and was developed and marketed by Fabre-Kramer Pharmaceuticals. [4] 4] It was approved for the treatment of major depressive disorder in the United States in September 2023. [4] The FDA rejected approval for gepirone in 2002 and 2004. [5] 1] It is taken orally.
Let's personalize your content